Abstract
Purpose
Fluorescence-guided surgery has been recommended for the diagnosis of bone margins in cases of mandibular osteonecrosis. In this article, we report a case in which a generic violet light was used in order to activate bone fluorescence after the administration of tetracycline derivatives, as an alternative to a specific, more expensive equipment that is commercially available for this purpose. The patient had been using alendronate for osteoporosis, resulting in medication-related osteonecrosis of the jaws.
Methods
The treatment protocol includes preoperative administration of doxycycline and the application of a generic violet light during surgery in order to observe the fluorescence of bone in response to excitation through the light emitted by this device.
Results
With an effective visualization of the limit between healthy and devitalized bone tissue, it was possible to perform the necrotic tissue removal. The lesion regressed from stage 2 to stage 0, with no clinical or radiographic evidence of necrotic bone.
Conclusions
These results suggest the feasibility of using a generic violet light source as a low-cost alternative for fluorescence-guided surgery.
Similar content being viewed by others
References
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1118. https://doi.org/10.1016/S0278-2391(03)00720-1
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American Association of Oral and Maxillofacial Surgeons Position Paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 1024(72):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Otto S, Ristow O, Pache C, Troeltzsch M, Fliefel R, Ehrenfeld M, Pautke C (2016) Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: a prospective cohort study. J Craniomaxillofac Surg 44:1073–1080. https://doi.org/10.1016/j.jcms.2016.05.018
Varol A (2010) Poster board number: 27: bone labeling and fluorescence-guided bone resection for BIONJ. J Oral Maxillofac Surg 68:75–76. https://doi.org/10.1016/j.joms.2010.06.110
Dahners LE, Bos GD (2002) Fluorescent tetracycline labeling as an aid to debridement of necrotic bone in the treatment of chronic osteomyelitis. J Orthop Trauma 16:345–346
Harvey BR, Ephros H, DeFalco RJ (2004) Tetracycline bone labeling in surgical management of chronic osteomyelitis: a case report. J Oral Maxillofac Surg 62:752–754. https://doi.org/10.1016/j.joms.2003.08.036
Pautke C, Bauer F, Bissinger O, Tischer T, Kreutzer K, Steiner T, Weitz J, Otto S, Wolff KD, Stürzenbaum SR, Kolk A (2010) Tetracycline bone fluorescence: a valuable marker for osteonecrosis characterization and therapy. J Oral Maxillofac Surg 68:125–129. https://doi.org/10.1016/j.joms.2009.05.442
Pautke C, Bauer F, Tischer T, Kreutzer K, Weitz J, Kesting M, Hölzle F, Kolk A, Stürzenbaum ST, Wolff KD (2009) Fluorescence-guided bone resection in bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67:471–476. https://doi.org/10.1016/j.joms.2008.09.037
Vignery A, Baron R (1980) Dynamic histomorphometry of alveolar bone remodeling in the adult rat. Anat Rec 196:191–200
Garetto LP, Tricker ND (1998) Remodeling of bone surrounding the implant interface. In: Garetto LP, Turner CH, Duncan RL (eds) Bridging gap between dental and orthopaedic implants. Proceedings of the 3rd Annual Indiana Conference, May 12–16. Indianapolis, IN, Indiana University School of Dentistry
Otto S, Ristow O, GeiB C, Kehl V, Berger M, Troeltzsch M, Koerdt S, Hohlweg-Majert B, Freudisperger C, Pautke C (2017) Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. Int J Oral Maxillofac Surg 46:157–166. https://doi.org/10.1016/j.ijom.2016.10.008
Ristow O, Pautke C (2014) Auto-fluorescence of the bone and its use for delineation of bone necrosis. Int J Oral Maxillofac Surg 43:1391–1393. https://doi.org/10.1016/j.ijom.2014.07.017
Giana HE, Silveira L Jr, Zângaro RA, Pacheco MTT (2003) Rapid identification of bacterial species by fluorescence spectroscopy and classification through principal components analysis. J Fluoresc 13:489–493
Arabi DS, Abdel-Salam ZA, Goda HA, Harith MA (2018) Utilization of laser induced fluorescence for the discrimination between two bacterial strains. J Lumin 194:594–599. https://doi.org/10.1016/j.jlumin.2017.09.019
Porcaro G, Amosso E, Rita Scarpella R, Fabrizio Carini F (2015) Doxycycline fluorescence-guided Er:YAG laser ablation combined with Nd:YAG/diode laser biostimulation for treating bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 119:6–12
Acknowledgements
We thank Dr. Edson Laureto, PhD (Department of Physics, Laboratory of Optics and Optoelectronics, State University of Londrina) for testing the wavelength of the violet light used for the procedure.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This article does not contain any studies with animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Ballardin, C., Pereira-Stabile, C.L. & Stabile, G.A.V. Use of a generic violet light in the surgical management of medication-related osteonecrosis of the jaws: a technical note. Oral Maxillofac Surg 22, 477–481 (2018). https://doi.org/10.1007/s10006-018-0718-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-018-0718-6